Cerebral perfusion pressure (CPP)

1. Bedside vignettes: why this matters in the PICU#

Vignette A. The 14-year-old SAH, "good CPP" after hyperosmolar therapy#

A 14-year-old presents with WFNS grade 3 SAH after a ruptured aneurysm. After coiling, ICP is 18 mmHg, MAP 95, CPP 77. Six hours later, ICP rises to 20 mmHg. The team gives 3% saline; MAP rises to 110 in response to volume expansion; new ICP 20 mmHg; new CPP 90 mmHg. The team notes that PRx has crept to +0.4 over the same window. The autoregulation curve has been pushed above the upper limit: the higher MAP has not translated into useful brain perfusion (autoregulation broken), and the higher CPP risks hyperperfusion, oedema, and a PRESS-like picture. Action: lower MAP target to bring CPP back to 65 to 75, recheck PRx in 1 hour. 2 4

Vignette B. The 4-month-old after non-accidental head injury#

A 4-month-old infant arrives in shock with non-accidental head injury, retinal haemorrhages, and a tense fontanelle. After resuscitation, MAP 50, ICP 18, CPP 32. The pediatric BTF age-banded CPP minimum for an infant is 40 to 50 mmHg. Action: raise MAP gently to 60 to 65 (fluid + noradrenaline if needed), reassess CPP, treat ICP if it climbs further. Within 30 min, MAP 62, ICP 18, CPP 44, in the lower band of the age target. The combination of age-appropriate CPP targeting plus ICP management is the bedside framework. 1 5

Vignette C. The 12-year-old TBI, the CPPopt is below the textbook target#

A 12-year-old severe TBI is on day 4 with ICP 16, MAP 80, CPP 64. The PRx-vs-CPP continuous fit (computed from 4 hours of data by the bedside ICM+) shows a U-curve with minimum PRx at CPP 58. This patient's CPPopt is 58, below the standard "60 to 70 for older child" textbook target. Aggressive MAP escalation to push CPP to 70 would shift this child to the right of his CPPopt, where PRx becomes more positive (impaired autoregulation, hyperperfusion). Action: target MAP to keep CPP near 58 to 63; reassess CPPopt every 1 to 4 hours. This is the central idea of individualised CPPopt: the textbook number is a starting heuristic; the U-curve is the truth. 2 6 3

2. What CPP is, and what it is not#

CPP is a derived number computed from two measured numbers. The two measured numbers are mean arterial pressure (from an arterial line) and intracranial pressure (from an EVD or parenchymal monitor). The derivation:

Three things follow immediately.

CPP is not cerebral blood flow. CPP is the driving pressure across the cerebral vascular bed. Cerebral blood flow (CBF) depends on CPP and on cerebrovascular resistance (CVR), through Ohm's law:

If autoregulation is intact, CVR adjusts so that CBF is roughly constant across a wide range of CPP (the Lassen plateau). If autoregulation is broken, CBF tracks CPP linearly. Same CPP, very different CBF in these two cases.

Same CPP, different paths. CPP 60 from MAP 75 + ICP 15 is a healthy brain on the autoregulation plateau. CPP 60 from MAP 100 + ICP 40 is a brain with markedly raised ICP and a high-MAP "compensation"; the cerebrovascular bed is exposed to high transmural pressure, the systemic circulation is under stress, and the autoregulation may be impaired. The path matters; the same number is not the same physiology. 7

CPP minima are age-banded. The mature cerebral autoregulation plateau (CPP 60 to 150 in adults) does not exist in the same form in young children. Neonates have a much narrower and lower autoregulation plateau (CPP ~30 to 50). The age-banded minimum CPP targets from the pediatric BTF guidelines:

3. The CPP triangle and the underlying physiology#

The classical Lassen autoregulation curve plots CBF on the y-axis against CPP (or MAP) on the x-axis. In a healthy adult, CBF is roughly constant from CPP ~60 to ~150 mmHg (the plateau). Below the lower limit (LLA), CBF falls and ischaemia ensues. Above the upper limit (ULA), CBF rises and hyperaemia / breakthrough oedema ensues. 8

Three modifications matter clinically.

The plateau is narrower and lower in children. Neonates: roughly CPP 30 to 50. Toddlers: roughly CPP 40 to 70. School-age: closer to adult. The exact bounds vary by individual, by injury, by sedation depth, and by autoregulation status. The age-banded minima above are empirical (from observational pediatric TBI data) rather than physiological.

Acute brain injury narrows or abolishes the plateau. PRx > +0.3, Mx > +0.3, or COx > +0.3 mean autoregulation is impaired; CBF tracks CPP passively in that range; the patient is functionally outside the plateau. Pushing CPP up does not produce useful CBF, and may produce oedema. 9 2

Individualised CPPopt (Aries 2012, Donnelly 2017, Beqiri 2024 COGiTATE): plot PRx against CPP across the previous 4 hours of data; fit a parabola; the vertex is CPPopt. Target the CPP within ±5 mmHg of CPPopt. In adult TBI, time spent further from CPPopt correlates with worse outcome (Aries 2012, Beqiri 2024). 2 4 10

4. The numbers: what to record at the bedside#

Document trend over hours, not single snapshots. Most modern PICU bedside platforms show CPP alongside MAP, ICP, and PRx in one trend strip.

5. What is normal? Age-banded CPP targets#

1 7 5.

6. What is abnormal? Pattern library and management triggers#

Decision tree: "what to do about this CPP"#

flowchart TD
  Read[CPP reading] --> Age{Age band}
  Age --> Low{CPP < age minimum?}
  Low -->|Yes| Cause{Low MAP or high ICP?}
  Cause -->|Low MAP| Vol[Volume, vasopressor]
  Cause -->|High ICP| ICP[Sedation, HOB, hyperosmolar]
  Cause -->|Both| Comb[Treat both]
  Low -->|No| High{CPP > 80 to 90 with PRx positive?}
  High -->|Yes| Lower[Lower MAP gently]
  High -->|No| Opt{CPPopt available?}
  Opt -->|Yes| Match{Within ±5 of CPPopt?}
  Match -->|Yes| Cont[Continue]
  Match -->|No| Retarg[Retarget MAP to bring CPP closer to CPPopt]
  Opt -->|No| Cont

7. Try it: interactive widgets#

8. CPP-driven management in detail#

8.1 Fixed thresholds (BTF / pediatric BTF)#

The simplest CPP framework. Maintain CPP above the age-banded minimum at all times. Treat ICP above 20 mmHg (guideline, all pediatric ages; emerging paediatric data point lower). The pediatric BTF 4th edition is the canonical reference. 1 11 7

8.2 The ICP-dose framework#

Guiza 2015 and Depreitere 2014 introduced the concept of ICP dose: the area-under-curve of ICP × time above threshold, which correlates with outcome better than peak ICP alone. The corollary CPP dose: time spent below CPP minimum × magnitude of the deficit also correlates with outcome. The dose framework integrates the trade-off between treating ICP and maintaining CPP. 12 6

8.3 Individualised CPPopt#

Compute PRx (or Mx, or COx) continuously. Plot PRx against CPP for the last 4 hours; fit a parabola. The vertex is CPPopt; target MAP so CPP sits within ±5 mmHg of CPPopt. Re-fit every 1 to 4 hours.

Pediatric data: Tas 2024 reported pediatric CPPopt feasibility in 50 children with severe TBI; time spent further from CPPopt correlated with worse outcome, consistent with adult data. 2 4 10 3

8.4 The risk of pushing CPP too high#

Three named harms:

1. ARDS / lung injury: aggressive fluid and vasopressor escalation to lift MAP increases lung-injury risk. The original CPP-targeted protocols (CPP > 70 in adults) were abandoned partly for this reason. 13
2. Cerebral hyperaemia and oedema: if autoregulation is broken, raising MAP pushes CBF up linearly; the resulting hyperaemia can cause vasogenic oedema, breakthrough bleeding, and worsen ICP.
3. PRESS-like syndrome: posterior reversible encephalopathy can be precipitated by hypertension, particularly in conditions with endothelial dysfunction (sepsis, eclampsia, post-transplant).

The upper bound matters. Modern CPP management is two-sided: too low is bad, too high is also bad. 2

8.5 The bedside MAP-titration ladder#

When CPP needs to be raised:

1. Fluid bolus (10 to 20 mL/kg crystalloid) if hypovolaemic; recheck CPP in 15 min.
2. Vasopressor (noradrenaline, sometimes phenylephrine; vasopressin in selected cases): start low, titrate to MAP target.
3. Sedation review: deep sedation can cause hypotension; review and adjust.
4. Posture: head-of-bed at 30°; abdominal compression / Valsalva avoided; jugular venous outflow unobstructed.
5. Reassess CPP after each step.

When CPP needs to be lowered:

1. Lower MAP target: titrate vasopressor down; use esmolol or labetalol if MAP needs more decisive control.
2. Address sympathetic surge: increase sedation if pain or agitation is driving MAP up.
3. Reassess autoregulation index (PRx, Mx, COx) to confirm pushing CPP back into the plateau.

8.6 When CPP and ICP are both stubbornly out of range#

The path matters. If ICP is the problem (sustained ICP above the guideline threshold of 20 mmHg, all ages, despite first-line measures), escalate ICP management (deeper sedation, hyperosmolar, possibly hypothermia, possibly decompressive craniectomy). Raising MAP alone in this setting often raises ICP further (autoregulation broken; volume goes to brain not vessel). If MAP is the problem (sepsis, haemorrhagic shock), restore MAP first; ICP often improves as cerebral perfusion is restored.

9. Clinical contexts: CPP across acute brain injuries#

9.1 Severe TBI#

The canonical indication. Pediatric BTF specifies age-banded CPP minima; the consensus statements (Kochanek 2019, Tasker 2023) emphasise that "ICP and CPP are both important" rather than a single number. Multimodal monitoring (ICP, PRx, PbtO2 where available) refines the CPP target. 1 7 5

9.2 Aneurysmal SAH#

Post-SAH CPP management balances vasospasm prevention (higher MAP supports collateral flow) against bleeding risk and the upper limit of autoregulation. AHA SAH guidelines suggest maintaining CPP and MAP within an individualised, multimodal framework. 14 15

9.3 Pediatric AIS#

Post-recanalisation hyperperfusion risk drives MAP-lowering decisions in the first 24 h. CPP per se is less the bedside framework here; MAP control with NIRS / TCD feedback is more relevant. 16

9.4 HIE and post-cardiac arrest#

Pediatric post-arrest CPP targets are not well-defined. AHA pediatric post-arrest guidelines suggest age-appropriate MAP targets, avoidance of hypotension, and avoidance of hyperthermia. Autoregulation indices (where available) refine the target. 17 18

9.5 Pediatric ECMO#

VA-ECMO patients have continuous MAP; CPP is a meaningful number even without pulsatility. The ELSO neurological guidelines recommend MAP-targeted care with neuromonitoring (NIRS, NPi, cEEG); explicit CPP targets are centre-dependent. 19 20

9.6 Meningitis and encephalitis with raised ICP#

Bacterial meningitis with fulminant cerebral oedema can require ICP / CPP management akin to TBI. Pediatric meningitis guidelines reference CPP only in the context of overall ICP / oedema management. 21 22

9.7 Brain-death determination#

CPP approaches or falls to zero in established brain death (ICP approaches MAP); TCD shows oscillating / pendular flow patterns. CPP is not a diagnostic criterion but is a useful corroborating bedside observation. 23 24

9.8 DKA cerebral oedema#

ICP rises during DKA-CO; CPP falls. Maintaining age-appropriate CPP during rehydration is part of the bedside management bundle alongside osmotherapy and HOB. 25 26

9.9 Refractory status epilepticus#

Continuous sedation for refractory SE can hypotensify and lower CPP. The PICU framework targets MAP and CPP within age-appropriate ranges while treating the seizure burden; vasopressor support is common. 27 28

10. Multimodal integration: CPP in the MMM/MNM stack#

11. Setup and technique#

11.1 Measuring MAP correctly#

1. Arterial line with a properly zeroed transducer at the phlebostatic axis.
2. Calibrate with mercury or per local protocol at start of shift.
3. Square-wave test to verify under- / over-damping; correct if abnormal.
4. Document MAP at consistent timestamps; the rolling 1-minute average is the standard input to PRx / CPPopt computation.

11.2 Measuring ICP correctly#

1. EVD or parenchymal probe placed by neurosurgery per local protocol.
2. Zeroing: EVD transducer at the tragus (foramen of Monro); parenchymal probes pre-calibrated and inserted.
3. Verify trace quality: clean P1-P2-P3 morphology, respiratory variation visible.
4. Document at consistent timestamps; pair with MAP.

11.3 Computing CPP and CPPopt#

1. Continuous CPP = MAP − ICP, computed beat-to-beat or every 1 to 10 s.
2. PRx computation: Pearson correlation of 10-s averages of ICP and MAP over a rolling 5-min window.
3. CPPopt computation: bin CPP values from the last 4 h into 5-mmHg windows; compute mean PRx in each bin; fit a parabola; the vertex is CPPopt.
4. Display: bedside platform (ICM+, Sickbay, or custom) shows CPP, PRx, and CPPopt as a continuous trend.

11.4 The bedside conversation#

1. Morning round: review the previous 24 h CPP, ICP, MAP, PRx, CPPopt trend.
2. Define the CPP target for the day: age-banded minimum OR individualised CPPopt OR multimodal-derived target.
3. Define the action triggers: CPP below X for Y min → escalate; CPP above Z with rising PRx → de-escalate.
4. Document the plan so the night team can act consistently.

11.5 Pediatric-specific considerations#

1. Age-banded targets mandatory; do not apply adult CPP 60 to 70 to an infant.
2. Lower stroke volume, so MAP responses to volume vary; intermittent boluses more useful than large continuous infusions.
3. Vasopressor selection: noradrenaline first-line for most pediatric CPP escalations; dopamine has fallen out of first-line use in many units.
4. Pediatric CPPopt evidence is sparse: treat the individualised target as a refinement of the age-banded floor, not a replacement.

11.6 Calibration drift and signal quality#

CPP and CPPopt are only as good as the underlying MAP and ICP signals. Daily transducer zeroing, regular square-wave testing, and prompt response to alarms (ICP probe drift, EVD over-drainage, arterial line damping) are operational essentials.

12. Pitfalls#

• CPP without context: same CPP, different paths; always document the MAP / ICP split and the autoregulation status.
• Treating CPP as the only goal: chasing CPP > 70 in an older child can cause ARDS / hyperaemic injury.
• Applying adult thresholds to children: a CPP of 50 is "low" in an adult but appropriate in a toddler.
• CPPopt without enough data: 4 hours of synchronised MAP / ICP / PRx are needed; less is unreliable.
• CPPopt during sedation changes: sedation hold can artefact the CPPopt fit for an hour.
• Ignoring autoregulation status: a "good" CPP in a patient with PRx +0.5 is not the same as a "good" CPP in a patient with PRx −0.1.
• Single-snapshot CPP: trend over hours matters more than a one-off number.
• Confusing CPP and CBF: CPP is the driving pressure; CBF depends on CVR; the two move together only when autoregulation is broken.
• Forgetting the upper bound: pediatric BTF gives a minimum but not a strict maximum; in practice, CPP > 85 in an older child should be questioned.
• Path-of-care confusion: CPP can be raised by raising MAP or by lowering ICP; the chosen path matters for the brain and the patient.

13. Combine with…#

• ICP: one of the two measured numbers that compose CPP.
• PRx: the autoregulation index that underpins CPPopt.
• CPPopt: the dedicated CPPopt page with workflow detail.
• Mx: TCD-derived autoregulation index for non-invasive CPPopt.
• COx: NIRS-derived autoregulation index.
• PbtO2: tissue-oxygen complement.
• Foundations: autoregulation: the physiology behind every CPP target.

14. Evidence summary#

15. Recent literature (2022 to 2025)#

• Beqiri 2024 COGiTATE trial: randomised feasibility trial of CPPopt-guided MAP management vs standard care in adult TBI; CPPopt arm achieved more time within ±5 mmHg of target with acceptable safety. 10
• Tas 2024 pediatric CPPopt feasibility: largest pediatric CPPopt cohort to date (n = 50 severe TBI); CPPopt computable and clinically actionable in pediatric ICU. 3
• Tas 2025 COGiTATE follow-up: longer-term outcomes data emerging. 34
• Tasker 2023 PCCM review: pediatric severe TBI management framework integrating CPP, CPPopt, multimodal monitoring. 5
• Figaji 2025 pediatric MMM consensus: positions CPPopt as tier-2 (specialist centre) modality in pediatric MNM. 29
• Helbok 2024 pediatric MMM: bedside operationalisation of CPP / CPPopt in pediatric multimodal stacks. 30

16. Self-check#